Africa & Middle East
Americas
Asia Pacific
COPD (chronic obstructive pulmonary disease) is a serious progressive lung disease affecting about 15–25% of adults over 40.1
The world health organisation (WHO) suggests that up to 65 million people worldwide are currently living with moderate to severe COPD.2
To help ease this burden, ResMed helps you provide individualised treatment for your patients with COPD … helping them breathe easier, and work towards a more promising picture with every breath.
Although there is currently no cure for COPD, treatments are available to help patients with their day-to-day relief and long-term disease management.
Overview of COPD including signs and symptoms, causes, stages, treatment, economics and patient outcomes. A global problem with economic consequences.
ResMed offers you intelligent non-invasive ventilation solutions that can help you tailor treatment to the unique and changing needs of your patients. From ventilators and masks to oxygen options and accessories, ResMed’s solutions work together to help patients breathe easier as they manage their condition.
Like all forms of mechanical ventilation, non-invasive ventilation supports a patient’s breathing.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). “Global Strategy for the Diagnosis, Management and Prevention of COPD, 2010.” (accessed November 9, 2015) Gold Report
2: World Health Organization. “Chronic respiratory diseases: Burden of COPD” (accessed November 9, 2015) http://www.who.int/gho/publications/world_health_statistics/en/
Middle-East (English)